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Abstract
Background: Surgical lifting and scraping is a well-known treatment for epithelial ingrowth, but treatment for
epithelial ingrowth on the centrally perforated laser in situ keratomileusis (LASIK) flap has not been well studied.
Case presentation: We present a patient who had epithelial ingrowth to the backside of the flap through a central
LASIK flap laceration with a stellate shape. The patient had undergone uncomplicated bilateral LASIK surgery 3 years
before the trauma. Because the epithelial ingrowth was suspected during the first visit 2 weeks after trauma, and
definite epithelial ingrowth was noted during the additional 2 week observation period, the ingrown epithelial tissue
was removed mechanically with a number 15 blade after lifting of the flap 4 weeks after the trauma. An amniotic
membrane overlay was applied over the cornea and was sutured tightly to the episclera to firmly press down the flap
to the remaining posterior stroma, to prevent growth of the epithelium again to the backside of the flap. At the last
follow-up visit, 5 months after surgery, the patient’s visual acuity remained stabilized with no sign of recurrent epithelial
ingrowth.
Conclusion: These results showed that an amniotic membrane patch can be a useful adjuvant in the treatment of
epithelial ingrowth, even on the central stellate laceration of the LASIK flap over the visual axis.
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Background
Epithelial ingrowth after laser in situ keratomileusis
(LASIK) has been reported to occur in 0–20 % of
cases [1–5]. Surgical lifting and epithelial ingrowth scrap-
ing is a well-known treatment for clinically significant
epithelial ingrowth with or without adjunctive treatments
such as ethanol, mitomycin C, phototherapeutic keratec-
tomy, or suturing of the flap [6–9]. Treatment for epithe-
lial ingrowth on the centrally perforated LASIK flap,
however, has not been comprehensively reported.
Human amniotic membrane has been used for ocular
surface reconstructions to treat various ocular surface
disorders such as chemical burns, symblepharon, per-
sistent epithelial defects, and sterile corneal ulcerations
[10, 11]. We have successfully applied an amniotic
membrane to inhibit the recurrence of the epithelial
ingrowth in linearly lacerated LASIK flap cases [12].
When the stellate laceration occurs at the central
LASIK flap, suturing the cornea, including the central
flap, would leave a scar from the suture track. Epithelial
ingrowth through the central stellate wound can recur
even with early scraping of epithelium from the poster-
ior surface of the flap and the anterior surface of the
posterior remaining stromal bed. To inhibit the regrowth
of the epithelium toward the space where the ingrown
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epithelia has occurred, tight apposition of the posterior
surface of the flap to the posterior remaining stromal
bed is necessary.
In the following report, we present a case of central
laceration of the flap with a stellate shape, through
which epithelial ingrowth occurred during the 4 weeks
after trauma. Flap lifting, mechanical epithelial scrapping
out, and a pressure patch using an amniotic membrane
graft were used to achieve a successful outcome.
Case presentation
A 33-year-old male was referred to our clinic for corneal
opacity with decreased visual acuity in the left eye after
injury by a sharp pebble 2 weeks earlier. He had under-
gone uncomplicated bilateral LASIK surgery 3 years
before the trauma, and good visual acuity had been
maintained. At the time of the injury, he was abroad and
treated with bandage contact lens (BCL) and anti-
inflammatory eyedrops by the local physician.
On examination at our clinic, the uncorrected distance
visual acuity (UCVA) was 20/60 and the best corrected
visual acuity (BCVA) with a spherical correction of −1.50
diopter was 20/40 in the left eye, while UCVA of the
right eye was 20/20. Slit-lamp examination of the left
eye revealed a 5.0 mm long vertical and central
stellate-shaped laceration crossing the centre of the
pupil with haze around the lacerated wound. There
were no signs of infection. Anterior segment Fourier-
domain optical coherence tomography (FD-OCT)
(RTVue-100; Optovue, Fremont, CA, USA) showed a
laceration with perforation of the LASIK flap and a
superficial laceration on the posterior remaining
stroma. Epithelial ingrowth to the backside of the flap
through the flap margin was suspected, but was not
definite in shape (Fig. 1). Gatifloxacin (0.3 %) (Gatiflo®;
Handok, Chungbuk, Korea) and 1 % prednisolone acetate
(Pred Forte®; Allergan, Irvine, CA, USA) drops were
prescribed for the left eye, four times daily.
Two weeks after the first visit to our clinic, epithelial
ingrowth was observed with more notable epithelial
cysts (Fig. 2a) with a decreased UCVA of 20/200. After
placing preplaced sutures along the flap margin at 4, 6,
and 8 o’clock positions to secure the pre-lifting edge,
half of the LASIK flap including the lacerated central
portion, was lifted gently with forceps (Fig. 3a). The
opaque material with several white cystic dots around
the laceration (Fig. 2a) was determined by slit-lamp
examination to be a grown epithelial sheet. Shallow
three-branched lacerations were also noted on the pos-
terior remaining stromal surface, corresponding to the
LASIK flap laceration area (Fig. 3a). The epithelium was
scraped out from both the posterior surface of the flap
and the surface of posterior remaining stromal bed with
a #15 Bard-Parker blade. After irrigation of the corneal
flap with balanced salt solution (BSS), the flap was
placed back to its original position by tightening the pre-
placed sutures (Fig. 3b). Additional interrupted sutures
were placed along the flap margin. Suturing the central
cornea near the pupil was avoided, because the lacer-
ation was over the pupil. Instead, preserved amniotic
Fig. 1 a Slit-lamp photograph of the left eye taken at the presenta-
tion at our clinic, showing a 5.0 mm long vertical lacerated LASIK
flap involving the centre of the pupil. b Anterior segment optical coher-
ence tomography (OCT) showing separation of Bowman’s layer after la-
ceration (black arrowhead). Epithelial ingrowth from the flap margin to
the backside of the flap was suspected, but was not definitely confirmed
using OCT (black asterisk)
Fig. 2 After 2 weeks, epithelial ingrowth and epithelial cysts (white
arrows) were noted in the slit-lamp photograph a and using OCT
b. The lacerated margin of Bowman’s layer of the LASIK flap (black
arrowhead) and lacerated and bent margin of the opposite LASIK flap
(black arrow) were noted using OCT
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membrane was placed over the entire cornea with the
amnion side facing the down position and was tightly
secured with 10–0 nylon sutures to the episclera, with a
tension facilitating pressing down of the corneal flap to
the posterior remaining stroma (Fig. 3c). The same
suturing procedure was repeated with the application of
another larger amniotic membrane to reinforce the
pressure force of the LASIK flap to the posterior
remaining stroma, and to lengthen the amniotic mem-
brane survival time. We used amniotic membrane frozen
from fresh foetal membrane (both amnion and chorion)
from the Severance Tissue Bank, because the lyophilized
one would be torn off especially at the suture site when
the membrane stretched for suturing. Ofloxacin (0.3 %)
(Ocuflox; Samil Pharmaceutical, Seoul, Korea) eye drops
were prescribed four times a day. The amniotic mem-
brane patch maintained its tightness and firm pressure
over the flap firmly 5 days after its application (Fig. 3d),
and was removed after 10 days postoperatively.
After removal of the amniotic membrane patch, cor-
neal opacity from the epithelial ingrowth disappeared,
with only a small amount of linear opacity remaining
along the lacerated LASIK flap margin. Corneal sutures
made at the LASIK flap margin were removed 1 week
after the amniotic membrane patch removal. At the
follow-up visits 1 and 5 months after the epithelial re-
moval, the patient’s UCVA and BCVA with a spherical
correction of +0.50 diopter were maintained at 20/40
and 20/20 in the left eye, respectively. There was no sign
of recurrence of epithelial ingrowth (Figs. 4 and 5).
Discussion
In treating a stellate-shaped lacerated LASIK flap wound
over the pupil accompanying epithelial ingrowth, there
is no new technique for attaching the flap to the poster-
iorly remaining stroma that results in complete inhib-
ition of epithelial ingrowth. We have previously reported
the effect of an amniotic membrane pressure patch for
the management of the epithelial ingrowth accompanied
by the LASIK flap trauma. The patients with epithelial
ingrowth after an intraoperative corneal defect could be
treated successfully by using an amniotic membrane as a
biological pressure patch [13]. In patient who had a
broadly flipped LASIK flap after trauma accompanied by
epithelial ingrowth, the amniotic membrane was used as
an overlay over the cornea as a biological pressure patch
after removing the ingrown epithelial sheet and reposi-
tioning of the flap [12]. In the present study, the stellate-
shaped laceration wound of the LASIK flap was located
on the visual axis. Epithelial ingrowth through the
Fig. 3 Intraoperative and postoperative photographs showing amniotic membrane pressure patch for inhibition of epithelial ingrowth after LASIK
flap laceration. a After introducing preplaced sutures along the flap margin at 4, 6, and 8 o’clock (white arrowheads), half of the LASIK flap including
lacerated central portion, was lifted gently with forceps. Shallow three-branched lacerations were noted on the posterior remaining stromal surface,
corresponding to the LASIK flap laceration area (black arrowheads). The epithelium was scraped out from both the posterior surface of the flap and the
surface of posterior remaining stromal bed with a #15 Bard-Parker blade. b The flap was placed back to its original position by tightening the preplaced
sutures. c Amniotic membrane was tightly sutured with 10–0 nylon to the episclera to cover the entire cornea with the amnion side facing the down
position, and the same suturing procedure was repeated with the application of another larger amniotic membrane. d The amniotic membrane patch
maintained the tightness with pressing down the flap firmly for 5 days after its application, and was removed 10 days after application
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lacerated wound of the flap to the interface between
the LASIK flap and the posteriorly remaining stroma
progressively interfered with vision. The operation was
performed 1 month after the trauma, because the pa-
tient presented to us 2 weeks after injury and another
2 weeks were required to confirm the progression of
the epithelial ingrowth. When epithelial removal is
performed later, the surgical approach must be adjusted
to allow more time for stromal remodeling by the
epithelium [14]. Our present case using an amniotic
membrane patch maintained a stable vision of 20/20
without any signs of recurrence of epithelial ingrowth
for 5 months.
Similar to our case, Meskin et al. reported the case of
central epithelial ingrowth caused by perforating corneal
injury [15]. Unlike our treatment, they sutured the
central LASIK flap in a similar manner commonly
carried out when the lesion is located peripherally and
placed BCL at the end of procedure. They reported
disappearance of epithelial ingrowth with no recurrence
over 1-year follow-up, however, final astigmatism of
1.25 diopter remained. Previous reports demonstrated
that flap margin suturing for epithelial ingrowth is a
safe technique with no evidence of flap striae or signifi-
cant change in spherical equivalence in manifest refrac-
tion [6, 14]. However, direct suture method on the
central flap lesion can cause deterioration of visual axis,
postoperative astigmatism, and iatrogenic creation of
epithelial cell tract [15, 16].
Upon the general management of epithelial ingrowth,
modalities used to facilitate flap adherence and prevent
fistulous epithelial tracts include sutures, fibrin glues
on peripheral edge, and BCL treatment. Inhibition of
offending epithelial ingrowth at the flap edge would
be very important when LASIK flap is intact and
dislocated [17]. However, in present report, the lacerat-
ing corneal injury with stellate shape caused epithelial
ingrowth directly from the central entry point without
peripheral flap dislocation. Furthermore, the lacerated
lesion also involved the posterior remaining stromal
bed. Therefore, it is essential to press down the central
portion of the cornea for proper management of the
our case. It is obvious that BCL application has benefi-
cial effects on wound healing, however, BCL is difficult
to press the center of flattened cornea by LASIK effect-
ively since it is made for the naïve cornea. In fact, the
Fig. 4 One month after surgery, mild stromal fibrosis (white arrowheads) was noted along the interface between the LASIK flap and posterior remaining
stroma in a a slit-lamp photograph, and b using OCT
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patient had been treated with BCL already before the
patient visited to our clinic and epithelial ingrowth
occurred with deteriorating vision within 2 weeks after
BCL use.
Because of the difficulty in preventing recurrence of
epithelial ingrowth, various removal methods of epithelial
cells have been proposed, that include simple scraping,
excimer laser phototherapeutic keratectomy, and the
use of adjuncts such as cryotherapy, alcohol, mitomycin
C, or sutures. The recurrence rate after scraping alone
has been reported as 44 % [5]. Adjunctive treatments to
lower this recurrence rate, however, did not result in a
significant difference compared to the results of simple
scraping. The use of 70 % isopropyl alcohol showed no
additional benefit over simple mechanical scraping in
the removal and prevention of epithelial ingrowth re-
currence following LASIK [7]. Moreover, compared
with mechanical debridement, some reports reported
that alcohol can induce keratocyte death and increase
inflammation [18]. Mitomycin C can inhibit corneal
wound healing [19], and phototherapeutic keratectomy
can induce irregular astigmatism and unpredictable
shifts in refraction [20]. These side effects prohibited
their use in treatment of the stellate-shaped laceration
of the LASIK flap.
The observed clinical effects of an amniotic membrane
include facilitation of epithelialization, maintenance of
a normal phenotype, and reduction of inflammation,
vascularization, and scarring [21]. These biological
characteristics may explain why the amniotic mem-
brane contributed to blocking the recurrence of epi-
thelium ingrowth in our case, although the patient
had a complicated laceration with torn flaps in three
directions. The elastic amniotic membrane, after being
tightly sutured to the episclera with expansion,
pressed down the lacerated flap margin firmly to the
posterior remaining stromal surface to inhibit epithe-
lial ingrowth to the LASIK flap interface, even though
a combined stromal laceration induced irregularity at
the LASIK flap interface.
Conclusion
Application of an amniotic membrane patch can be a
useful adjuvant in the treatment of a stellate-shaped
central LASIK flap laceration when epithelial ingrowth
occurs over the visual axis.
Fig. 5 Five months after surgery, there was no sign of recurrent epithelial ingrowth. Fibrotic tissue (white arrowheads) was noted along the
interface between the LASIK flap and the posterior remaining stroma in a the slit-lamp photograph and in b using OCT
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